How One Company Pivoted From Cancer To Coronavirus And Designed A Virus-Blocking Drug In 10 Weeks

Scientists at Neoleukin Therapeutics applied their protein design technology to the new coronavirus and created an antiviral molecule in record time.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive